Group-Based Trajectory Modeling for Assessing Oral Endocrine Therapy Adherence Pattern in HER-positive Breast Cancer Patients at DHR Health in the Rio Grande Valley
Batool Fatima(University of Houston), Susan Abughosh(University of Houston), Rebecca Syed Sheriff(Doctors Hospital at Renaissance), Meghana V. Trivedi(University of Houston), Ronnie Ozuna(Doctors Hospital), Phillip Shayne Pruneda(University of Houston)
Cited by 0
Related Papers
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273
Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize
|Cancer Research|2018|221
Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications
|Breast Care|2013|200
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer
|Proceedings of the National Academy of Sciences|2016|185
The changing role of ER in endocrine resistance
|The Breast|2015|133